KORU Medical Systems, Inc. (KRMD) vs Atrium Therapeutics, Inc. (RNA)
A side-by-side comparison of KORU Medical Systems, Inc. and Atrium Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KRMD
KORU Medical Systems, Inc.
$2.99HealthcareDelayed quote: Oct 6, 2026, 12:53 PM EDT
RNA
Atrium Therapeutics, Inc.
$7.95HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT
Total return — KRMD vs RNA
growth of $100 · dividends reinvested · last 1yKRMD -38.8% (-38.8%/yr)RNA -46.0% (-46.0%/yr)KRMD compounded faster over this window
KRMD RNA
KRMD vs RNA: by the numbers
- •KRMD is the larger company ($137M vs $136M market cap).
- •Both run net losses; KRMD's is the smaller (-4.03% vs -396.52% net margin).
Metrics side by side
Valuation
| Metric | KRMD | RNA |
|---|---|---|
| P/S ratio | 3.04 | 5.79 |
| P/B ratio | 7.60 | 0.63 |
| FCF yield | 0.19% | N/A |
Profitability
| Metric | KRMD | RNA |
|---|---|---|
| Gross margin | 61.99% | 97.90% |
| Operating margin | -3.66% | -410.23% |
| Net margin | -4.03% | -396.52% |
| ROE | -10.08% | -43.42% |
| ROIC | -7.95% | -38.45% |
Growth (annualized)
| Metric | KRMD | RNA |
|---|---|---|
| Revenue CAGR (5Y) | 16.42% | N/A |
| Total return CAGR (5Y) | 1.60% | N/A |
Go deeper
Dig into the metrics
KORU Medical Systems ROEAtrium Therapeutics ROEKORU Medical Systems operating marginAtrium Therapeutics operating marginKORU Medical Systems revenue growthAtrium Therapeutics revenue growthKORU Medical Systems free cash flowAtrium Therapeutics free cash flow
KORU Medical Systems & Atrium Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.